US Lymphedema Treatment Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - COVID-19 Impact and Country Analysis By Condition Type (Primary Lymphedema and Secondary Lymphedema), Treatment Type (Laser Therapy, Compression Devices & Bandaging, Drug Therapy, Physiological Procedures, Debulking Procedures, and Others), and End User (Hospitals, Clinics, Clinical Research Organization, and Others)

No. of Pages: 132    |    Report Code: BMIRE00028504    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
US Lymphedema Treatment Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. US Lymphedema Treatment Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. US Lymphedema Treatment Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1
  • 5.1.2 Rising incidence of cancer-related lymphedema
  • 5.1.3 Growing demand for compression therapy
  • 5.1.4 Increased awareness of lymphedema management
5.2 Market Opportunities
  • 5.2.1
  • 5.2.2 Advancements in minimally invasive treatments
  • 5.2.3 Expansion in home-based care solutions
  • 5.2.4 Demand for wearable compression devices
5.3 Future Trends
  • 5.3.1
  • 5.3.2 Development of AI-powered monitoring tools
  • 5.3.3 Use of smart textiles in treatment
  • 5.3.4 Focus on patient-centric care approaches
5.4 Impact of Drivers and Restraints

6. US Lymphedema Treatment Market Regional Analysis

6.1 US Lymphedema Treatment Market Overview
6.2 US Lymphedema Treatment Market Revenue 2020-2028 (US$ Million)
6.3 US Lymphedema Treatment Market Forecast Analysis

7. US Lymphedema Treatment Market Analysis – by Condition Type

7.1 Primary Lymphedema
  • 7.1.1 Overview
  • 7.1.2 Primary Lymphedema: US Lymphedema Treatment Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Secondary Lymphedema
  • 7.2.1 Overview
  • 7.2.2 Secondary Lymphedema: US Lymphedema Treatment Market – Revenue and Forecast to 2031 (US$ Million)

8. US Lymphedema Treatment Market Analysis – by Treatment Type

8.1 Laser Therapy
  • 8.1.1 Overview
  • 8.1.2 Laser Therapy: US Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Compression Devices & Bandaging
  • 8.2.1 Overview
  • 8.2.2 Compression Devices & Bandaging: US Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)
8.3 Drug Therapy
  • 8.3.1 Overview
  • 8.3.2 Drug Therapy: US Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Physiological Procedures
  • 8.4.1 Overview
  • 8.4.2 Physiological Procedures: US Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Debulking Procedures
  • 8.5.1 Overview
  • 8.5.2 Debulking Procedures: US Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9. US Lymphedema Treatment Market Analysis – by End User

9.1 Hospitals
  • 9.1.1 Overview
  • 9.1.2 Debulking Procedures: US Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Clinics
  • 9.2.1 Overview
  • 9.2.2 Debulking Procedures: US Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Clinical Research Organization
  • 9.3.1 Overview
  • 9.3.2 Debulking Procedures: US Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)

10. US Lymphedema Treatment Market – United States Analysis

10.1 United States
  • 10.1.1 US Lymphedema Treatment Market Breakdown, by Key Country, 2023 and 2028 (%)
  • 10.1.1.1 US Lymphedema Treatment Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 United States : US Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.1.1 United States : US Lymphedema Treatment Market Breakdown, by Condition Type
    • 10.1.1.1.2 United States : US Lymphedema Treatment Market Breakdown, by Treatment Type
    • 10.1.1.1.3 United States : US Lymphedema Treatment Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. US Lymphedema Treatment Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 BIOCOMPRESSION SYSTEMS
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Tactile Medical
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Smith & Nephew
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Essity AB
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Lohmann & Rauscher GmbH & Co. KG
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 SIGVARIS GROUP
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 ThermoTek
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Huntleigh Healthcare Limited
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 3M
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 Airos Medical, Paul Hartmann AG
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - US Lymphedema Treatment Market

  1. BIOCOMPRESSION SYSTEMS
  2. Tactile Medical
  3. Smith & Nephew
  4. Essity AB
  5. Lohmann & Rauscher GmbH & Co. KG
  6. SIGVARIS GROUP
  7. ThermoTek
  8. Huntleigh Healthcare Limited
  9. 3M
  10. Airos Medical, Paul Hartmann AG
us-lymphedema-treatment-market